Harvard University has announced that they will not be removing the name of the Sackler family, whose company Purdue Pharma produces the opioid painkiller OxyContin, from campus buildings. This decision comes despite protests from parents who have lost children to fatal overdoses of the drug. The university’s decision was met with disappointment and frustration from those who believe that the Sackler family’s association with the opioid crisis should be acknowledged and addressed.
The Sackler family has faced numerous lawsuits and backlash for their role in fueling the opioid epidemic through the aggressive marketing of OxyContin. Many believe that Harvard’s decision not to remove the family’s name from campus buildings is a missed opportunity to hold them accountable for their actions.
Harvard defended their decision by stating that they do not remove the names of donors from buildings, as doing so would set a precedent for future controversies. The university emphasized the importance of upholding their agreements with donors and honoring their contributions to the institution.
However, critics argue that maintaining the Sackler name on campus buildings sends the wrong message and perpetuates the stigma and pain experienced by those impacted by the opioid crisis. They believe that Harvard should take a stand against the Sackler family’s actions and demonstrate their commitment to addressing the public health crisis caused by opioids.
Moving forward, the debate over the Sackler family’s legacy at Harvard is likely to continue, as advocates for accountability and transparency push for greater recognition of the harm caused by Purdue Pharma’s products. Despite the university’s decision, the controversy surrounding the Sackler name and its connection to the opioid epidemic is far from over.
Source
Photo credit www.bostonherald.com